International recommendations for consumption of long-chain omega-3 fatty acids. 2007

William S Harris
Sanford Research/USD, Sanford School of Medicine, University of South Dakota, Sioux Falls, South Dakota 57105, USA. bill.harris@usd.edu

As an appreciation of the cardioprotective properties of the long-chain, fish-oil-derived omega-3 fatty acids (eicosapentaenoic and docosahexaenoic acids) has grown, so too have official dietary guidelines. Health organizations and government agencies are typically recommending intakes that either maintain the status quo (about 100-200 mg/day in most western countries) or are intended to actively reduce risk for cardiovascular disease. The latter are around usually 400-600 mg/day, an amount likely to stimulate commercial interests to fortify foods with omega-3 fatty acids. Fortification is perhaps the best long-term solution to the chronically-low intake of omega-3 fatty acids that plagues western cultures.

UI MeSH Term Description Entries
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D005228 Fatty Acids, Essential Long chain organic acid molecules that must be obtained from the diet. Examples are LINOLEIC ACIDS and LINOLENIC ACIDS. Acids, Essential Fatty,Essential Fatty Acids
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015525 Fatty Acids, Omega-3 A group of unsaturated fatty acids occurring mainly in fish oils, with three double bonds at particular positions in the hydrocarbon chain. N-3 Fatty Acid,Omega-3 Fatty Acid,Omega-3 Fatty Acids,n-3 Fatty Acids,n-3 Oil,n3 Oil,Omega 3 Fatty Acids,n-3 Oils,n-3 PUFA,n-3 Polyunsaturated Fatty Acid,n3 Fatty Acid,n3 Oils,n3 PUFA,n3 Polyunsaturated Fatty Acid,Acid, N-3 Fatty,Acid, Omega-3 Fatty,Fatty Acid, N-3,Fatty Acid, Omega-3,Fatty Acid, n3,N 3 Fatty Acid,Oil, n-3,Oil, n3,Omega 3 Fatty Acid,PUFA, n-3,PUFA, n3,n 3 Fatty Acids,n 3 Oil,n 3 Oils,n 3 PUFA,n 3 Polyunsaturated Fatty Acid
D017408 Guidelines as Topic Works about a systematic statement of policy rules or principles. Guidelines may be developed by government agencies at any level, institutions, professional societies, governing boards, or by convening expert panels. For guidelines in the field of health care and clinical medicine, PRACTICE GUIDELINES AS TOPIC is available. Guidelines as Topics

Related Publications

William S Harris
July 2013, Prostaglandins, leukotrienes, and essential fatty acids,
William S Harris
January 2013, Prostaglandins, leukotrienes, and essential fatty acids,
William S Harris
October 2011, American journal of hypertension,
William S Harris
May 2007, The Journal of pediatrics,
William S Harris
March 2018, Current opinion in clinical nutrition and metabolic care,
William S Harris
January 1998, World review of nutrition and dietetics,
William S Harris
November 2014, Der Urologe. Ausg. A,
William S Harris
November 2014, Military medicine,
William S Harris
April 2013, PharmaNutrition,
Copied contents to your clipboard!